About: Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 22 May 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2019 (fr) artículu científicu espublizáu en mayu de 2019 (ast) im Mai 2019 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована в травні 2019 (uk) scientific article published on 22 May 2019 (en)
publication date	wds:Q64279153-11AA76E1-F654-4D81-84B8-F8634D389E2C
publication date	2019-05-22 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64279153-4A1CD7F0-C32A-4A0A-A0BB-AC12C8D405C1
language of work or name	English
cites work	wds:Q64279153-104BF4AF-77EB-4556-8D86-6158EBB90CDB wds:Q64279153-1F788DA2-9BAE-43D6-992C-16EAED4FBB2C wds:Q64279153-29F0C5D5-3266-4866-9BC4-4A948F0886CA wds:Q64279153-319F94E1-CE98-431A-BEAD-623DAC753459 wds:Q64279153-3C568FC8-2109-448E-9B34-8953C053C1BB wds:Q64279153-3F0B4BCF-BA0A-4BEA-BFB6-C93C216F0A06 wds:Q64279153-4303DA44-DF38-41E1-8013-67B5CDAC1799 wds:Q64279153-49989841-7D7D-4BDA-A3DD-39C73023C87A wds:Q64279153-52B1D1D7-A0B1-4F25-93DB-C5F36FCE735F wds:Q64279153-59D0A3FF-7B85-47D9-9763-9F3CCAD2668B wds:Q64279153-630F883A-88C0-4D35-98CC-1FDEC9F98B26 wds:Q64279153-891B5C7A-CC25-4F17-9D4B-F18BBCA70171 wds:Q64279153-8A4C8485-6E2D-403F-8587-ED3EE55AED34 wds:Q64279153-92DF362A-B62F-4547-92B9-0E7137FB2C9F wds:Q64279153-96121524-8D7D-4FCA-B33B-3242DA48FE29 wds:Q64279153-997FCEED-5C15-40B2-A7C6-3B9CD4A79E46 wds:Q64279153-9EB2EB1B-428B-4F9D-BAFF-4AF0D8C87281 wds:Q64279153-A5FFB153-EFA3-4931-AE9A-304974511251 wds:Q64279153-BC81BD18-F700-4301-BD66-E785D81C35FA wds:Q64279153-CAE9ED67-FC66-44C9-A3C7-98EC5C28CBBF wds:Q64279153-D081D3EB-2E2C-4BDB-A4D9-6BF7664F6875 wds:Q64279153-D493830A-4F6A-4DBD-A212-EA8DFDF1C09E wds:Q64279153-D732F8F4-722C-4876-B25C-EE74C2FD185F wds:Q64279153-D90EAD2D-1E27-4C1C-B979-437DC1062E7F wds:Q64279153-DFAE6136-D6D0-4E35-A76B-3685F8FDA42D wds:Q64279153-E8B86522-3C2A-4295-87F9-EC2F69343902 wds:Q64279153-FD03CF5C-AA0E-45BC-81C2-8144D2CB8251
cites work	Comparison of long-term survival and toxicity of cisplatin delivered weekly versus every three weeks concurrently with intensity-modulated radiotherapy in nasopharyngeal carcinoma Global cancer statistics, 2012 Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck Nasopharyngeal carcinoma Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial stagi Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial. Dose delivery analysis of weekly versus 3-weekly cisplatin concurrent with radiation therapy for locally advanced nasopharyngeal carcinoma (NPC). Dose intensity comparison between weekly and 3-weekly Cisplatin delivered concurrently with radical radiotherapy for head and neck cancer: a retrospective comparison from New Cross Hospital, Wolverhampton, UK Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02). Present status of management of nasopharyngeal carcinoma Comparison of intensity-modulated radiotherapy using helical tomotherapy and segmental multileaf collimator-based techniques for nasopharyngeal carcinoma: dosimetric analysis incorporating quality assurance guidelines from RTOG 0225. Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trial. Plasma Fibrinogen Correlates with Metastasis and is Associated with Prognosis in Human Nasopharyngeal Carcinoma Chemoradiotherapy enhanced the efficacy of radiotherapy in nasopharyngeal carcinoma patients: a network meta-analysis
author name string	wds:Q64279153-28B0F2E3-14D6-4D94-A127-7B7582A5E1F3 wds:Q64279153-50CB0C70-BA5A-452C-AC39-8621A554AF40 wds:Q64279153-5157FE9D-5457-4D71-9BBB-C2C6DF002EE7 wds:Q64279153-6C883546-AB1A-4373-B770-0D325CB7AEE6 wds:Q64279153-B309E944-5BEA-426A-8529-BC369E6E0B7E wds:Q64279153-B42AD5C6-1FB0-4222-A392-1EAB8898AD4A wds:Q64279153-CE31761A-42DC-448E-B9DE-B1998BA8A6A9 wds:Q64279153-D36A9D2D-326D-4181-A22B-528165F1C608
author name string	Xia Wang Jun Dong Chang Jiang Pili Hu Xiuyu Cai Shasha He Jiangui Guo Kailin Wang
rdfs:label	Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma (en) Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma (nl)
skos:prefLabel	Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma (en) Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma (nl)
name	Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma (en) Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma (nl)
author	wds:Q64279153-68E3F4FF-346C-4992-8682-038506C9FE85
author	Xicheng Wang
title	wds:Q64279153-741378FD-A1D7-42E6-9223-C3322C44CE5D
title	Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma (en)
page(s)	wds:Q64279153-874C8BC1-A837-432D-A4D4-6A6F0E037228
page(s)	482
instance of	wds:Q64279153-986AF5C3-3375-41A3-B196-D181AEA31C3F
instance of	scholarly article
main subject	wds:Q64279153-25849815-9F4C-4F0E-9361-10B7D6C0B8F7
main subject	cisplatin
PubMed ID	wds:Q64279153-7D6872F5-0DF8-4DE6-83E2-41335825C799
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31117967
PubMed ID	31117967

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software